Share
Market Research Report

HSV TESTING MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By HSV TypeHSV-2 Testing · HSV-1 Testing · and HSV Type-Unspecified/Combined Tests
  • By TypeDirect Detection or Culture Test (Viral Culture) · Molecular Test (PCR Tests, TMA Tests, NAATs etc.) · Serological Tests (Antibody Detection etc.) · and Rapid Antigen Tests (Immunochromatographic) · and Others (Prenatal Screening Panels and Home Collection Kits, etc.)
  • By Sample TypeBlood/Serum/Plasma · Vesicular Swab/Fluid · Ulcer/Crust Swab · Cerebrospinal Fluid (CSF) · and Other Body Fluids (e.g., Bronchoalveolar Lavage)
  • By Age GroupInfants and Neonates · Children · Adults · and Elderly
  • By ApplicationClinical Disease Diagnosis · Epidemiological Studies (Screening) · Surveillance and Monitoring · and Others
  • By End UserHospitals · Clinical Diagnostic Laboratories · Home Care Settings · Point-of-care Settings · Blood Banks and Plasma Collection Centers · and Others (Research and Academic Institutes)
  • By GeographyNorth America · Latin America · Europe · Asia Pacific · Middle East & Africa
  • Published In10 Mar 2026
  • Report CodeCMI8344
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033

Market Segmentation

  • HSV Type Insights (Revenue, USD Mn, 2021 - 2033)

    • HSV-2 Testing
    • HSV-1 Testing
    • HSV Type-Unspecified/Combined Tests
  • Type Insights (Revenue, USD Mn, 2021 - 2033)

    • Direct Detection or Culture Test (Viral Culture)
    • Molecular Test (PCR Tests, TMA Tests, NAATs etc.)
    • Serological Tests (Antibody Detection etc.)
    • Rapid Antigen Tests (Immunochromatographic)
    • Others (Prenatal Screening Panels and Home Collection Kits, etc.)
  • Sample Type Insights (Revenue, USD Mn, 2021 - 2033)

    • Blood/Serum/Plasma
    • Vesicular Swab/Fluid
    • Ulcer/Crust Swab
    • Cerebrospinal Fluid (CSF)
    • Other Body Fluids (e.g., Bronchoalveolar Lavage)
  • Age Group Insights (Revenue, USD Mn, 2021 - 2033)

    • Infants and Neonates
    • Children
    • Adults
    • Elderly
  • Application Insights (Revenue, USD Mn, 2021 - 2033)

    • Clinical Disease Diagnosis
    • Epidemiological Studies (Screening)
    • Surveillance and Monitoring
    • Others
  • End User Insights (Revenue, USD Mn, 2021 - 2033)

    • Hospitals
    • Clinical Diagnostic Laboratories
    • Home Care Settings
    • Point-of-care Settings
    • Blood Banks and Plasma Collection Centers
    • Others (Research and Academic Institutes)
  • Regional Insights (Revenue, USD Mn, 2021 - 2033)

    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • GCC Countries
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • North Africa
      • Central Africa